Erie Indemnity (ERIE)
(Delayed Data from NSDQ)
$406.11 USD
-4.48 (-1.09%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $405.90 -0.21 (-0.05%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$406.11 USD
-4.48 (-1.09%)
Updated Nov 14, 2024 04:00 PM ET
After-Market: $405.90 -0.21 (-0.05%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum F VGM
Zacks News
Erie Indemnity (ERIE) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 22.75% and 6.05%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FVD
Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FVD
Erie Indemnity (ERIE) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Erie Indemnity (ERIE) delivered earnings and revenue surprises of 2.15% and 5.40%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
EverQuote (EVER) Rallies 137.7% in a Year: More Room to Run?
by Zacks Equity Research
EverQuote (EVER) gains from reduced operating expenses, the enhancement of its platform via machine learning and artificial intelligence, and expected recovery in the auto insurance business.
Brown & Brown (BRO) Gains 34% in a Year: Will the Rally Last?
by Zacks Equity Research
Brown & Brown (BRO) stock rallies on the back of higher core commissions and fees, new business, strategic acquisitions, strong financial position and effective capital deployment.
Reasons Why Investors Should Retain Arthur J. Gallagher (AJG)
by Zacks Equity Research
Arthur J. Gallagher (AJG) is poised to gain from the solid performance of its Brokerage and Risk Management segments, strategic buyouts and optimistic growth projections.
Key Highlights From CNO Financial's (CNO) Optavise Report
by Zacks Equity Research
CNO Financial's (CNO) Annual Benefits Broker Survey highlights the growing requirements of broker partners to address employers' regulatory and compliance management concerns.
Why You Should Retain American International (AIG) Stock Now
by Zacks Equity Research
Rising premiums, cost control efforts, streamlining of operations and increasing rates poise American International (AIG) well for growth.
Erie Indemnity (ERIE) is an Incredible Growth Stock: 3 Reasons Why
by Zacks Equity Research
Erie Indemnity (ERIE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Intercontinental (ICE), Freddie Mac Join to Enhance Loan Quality
by Zacks Equity Research
Intercontinental (ICE) and Freddie Mac collaborate to improve loan quality and reduce defects in the loan origination process.
Sun Life (SLF) Expands Family Leave Insurance Product in Florida
by Zacks Equity Research
Sun Life (SLF) bridges the gap of funding for small-size and mid-size firms, which enable them to provide paid family leave for their employees.
Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FVD
Compelling Reasons to Hold on to Marsh & McLennan (MMC) Stock
by Zacks Equity Research
Marsh & McLennan (MMC) gains from strong segmental contribution, better rate hikes and solid growth in operating cash flows.
Recent Price Trend in Erie Indemnity (ERIE) is Your Friend, Here's Why
by Zacks Equity Research
Erie Indemnity (ERIE) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
AON Acquires Humn.ai to Enhance Fleet & Mobility Offerings
by Zacks Equity Research
AON buys Humn.ai in a bid to provide innovative offerings for fleet and mobility clients.
Here's Why You Should Retain Arthur J. Gallagher (AJG) Stock
by Zacks Equity Research
Arthur J Gallagher (AJG) is poised to grow from the solid performance of its Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.
3 Reasons Growth Investors Will Love Erie Indemnity (ERIE)
by Zacks Equity Research
Erie Indemnity (ERIE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Marsh & McLennan's (MMC) Mercer SelectRx to Lower Pharmacy Spend
by Zacks Equity Research
Marsh & McLennan's (MMC) sub-unit Mercer launches a tech-enabled solution to generate higher cost savings for employees on specialty drugs and subsequently, drive its revenues.
All You Need to Know About Erie Indemnity (ERIE) Rating Upgrade to Buy
by Zacks Equity Research
Erie Indemnity (ERIE) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Erie Indemnity (ERIE) Is a Great Choice for 'Trend' Investors, Here's Why
by Zacks Equity Research
Erie Indemnity (ERIE) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.
Should First Trust Value Line Dividend ETF (FVD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FVD
Willis Towers Watson (WTW) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Willis Towers Watson (WTW) delivered earnings and revenue surprises of 5.68% and 0.32%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) Surges 20.8%: Is This an Indication of Further Gains?
by Zacks Equity Research
eHealth (EHTH) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Is First Trust Value Line Dividend ETF (FVD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FVD